Background illustration for clinical trials search

Paid Clinical Trials Edmonton

Discover 447 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Edmonton, Calgary, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

for
Stroke, Atrial Fibrillation
Location: Edmonton, Calgary, Medicine Hat, Saskatoon, Regina,
Sponsor: Population Health Research Institute

Sex: All

Age: 55+

Code: NCT03968393

Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Edmonton, Calgary, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events

for
Acute Kidney Injury
Location: Edmonton, Calgary
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT05806645

Recruiting

The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices

for
Intracranial Aneurysm, Brain Aneurysm,
Location: Edmonton, Winnipeg, Hamilton, Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT03936647

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Treatment of Brain AVMs (TOBAS) Study

for
Unruptured Brain Arteriovenous Malformation,
Location: Edmonton, Albuquerque NM, Montreal, Boston MA,
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 5+

Code: NCT02098252

Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Edmonton, Calgary, Spokane WA, Vancouver, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase3, Recruiting

Cardiac Sarcoidosis Multi-Center Prospective Cohort

for
Cardiac Sarcoidosis
Location: Edmonton, Calgary, Regina, Vancouver, London, Newmarket,
Sponsor: Ottawa Heart Institute Research Corporation

Sex: All

Age: 18 - 70+

Code: NCT01477359

Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

for
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor,
Location: Edmonton, Calgary, Spokane WA, Vancouver, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT04322318

Phase2, Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

for
Acute Myeloid Leukemia,
Location: Edmonton, Calgary, Kalispell MT, Sandpoint ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05564390

Phase2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Edmonton, Calgary, Spokane WA, Vancouver, Seattle WA,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase1, Phase2, Recruiting

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

for
Childhood Extracranial Germ Cell Tumor,
Location: Edmonton, Calgary, Spokane WA, Missoula MT,
Sponsor: Children's Oncology Group

Sex: All

Age: 0+

Code: NCT03067181

Phase3, Recruiting

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Edmonton, Calgary, Spokane WA, Vancouver, Seattle WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT04684368

Phase2, Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 5 - 60

Code: NCT05675410

Phase3, Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 30

Code: NCT06172296

Phase3, Recruiting

Project: Every Child for Younger Patients With Cancer

for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 25

Code: NCT02402244

Recruiting

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for
Metastatic Malignant Neoplasm in the Lung,
Location: Edmonton, Calgary, Spokane WA, Seattle WA, Renton WA,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 50

Code: NCT05235165

Phase3, Recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for
Acute Myeloid Leukemia
Location: Edmonton, Calgary, Saskatoon, Spokane WA, Vancouver,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT04293562

Phase3, Recruiting

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

for
Atrial Fibrillation, Stroke, Bleeding
Location: Edmonton, Salt Lake City UT, Murray UT, Rochester MN,
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT04045665

Phase3, Recruiting